日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Companies

Biotech boom, pride of Anhui

By Zhu Lixin (China Daily) Updated: 2016-07-19 08:14

Biotech boom, pride of Anhui

A bird's-eye view of the world's largest biotech drug production base in Hefei, Anhui province. The facility is shaped in the form of antibody ATCG. [Photo provided to China Daily]

Beijing-based Sinobioway Group Co Ltd, a major biotech company in China, is building the world's largest biotech drug production base at the Bantang township in Hefei, capital of Anhui province in East China.

The facility, shaped in the form of antibody ATCG and to be called the Bantang Bioeconomy Experimental Zone, will have 100 production lines to be completed in 10 to 15 years. The first five lines will be completed by the end of this year.

Work on another 10 will also start later this year, said Cao Wenbo, president of Anhui Sinobioway Bioeconomy Group, a subsidiary of Sinobioway Group.

The zone covers an area of 31 sq km. A 400,000-sq-meter plant is almost ready; the next two phases will take up 600,000 sq m.

Cao said infrastructure excluding the production lines will see an investment of 1.5 billion yuan ($224.3 million), which is being provided by the Hefei government.

Wu Cunrong, Party chief of Hefei city, said: "We believe the biotech drug sector will see enormous growth opportunities in future, so we will surely support such companies."

The company, Cao said, will repay the money in five years "so that we can have more money for mergers and acquisitions. We have enough money to reach the goal."

There are dozens of funds to back the ambitious project, which is expected to cost billions of yuan, he said.

"Instead of starting from the R&D stage, Sinobioway is more interested in buying drug patents and firms at home and abroad. Biotech drug production has been very profitable. But starting everything from R&D will be too time-consuming and risky. You may spend years but get nothing."

He said buying patents and firms will bring the company high profits quickly. During the process, it will also develop its own drugs.

This business model has marked the collaboration between Sinobioway and BioAlta, a San Diego-based company focused on the development of Conditionally Active Biologic antibody therapeutics.

In 2015, the two companies forged a strategic collaboration for the development and commercialization of select CAB antibodies and other CAB-based therapeutics in China. "Production of all the drugs will be based in Hefei," said Cao.

BioAlta would receive more than $70 million in payments and investment from Sinobioway in a year, according to their agreement.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 久久成年视频 | 久久成人av | 亚洲国产一级 | 日少妇视频 | 久久久久久亚洲精品 | 天天看天天摸天天操 | 日韩国产一区二区三区 | 欧美成人做爰大片免费看黄石 | 午夜在线观看影院 | 亚洲欧美一 | 超碰pron | 久久婷婷六月 | 精品久久久精品 | 日韩中文字幕免费在线观看 | 久久精品成人一区二区三区蜜臀 | 黄色一级大片在线免费观看 | 青青草原在线免费观看视频 | 美女中文字幕 | 久久亚洲精品小早川怜子 | 麻豆精品在线视频 | 美女激情av | 亚洲精品网站在线播放gif | 亚洲在线视频网站 | 日韩精品专区 | 欧美整片第一页 | 国产又粗又黄的视频 | 亚洲免费久久 | 天天视频国产 | 丁香婷婷久久久综合精品国产 | 亚洲女人网 | 淫亚洲| 国产 日韩 欧美 综合 | 四虎影视8848 | 在线中文字幕视频 | 亚洲精品福利视频 | 国产 日韩 欧美 综合 | 亚洲在线精品 | 全国男人天堂网 | 免费a视频在线观看 | 亚洲成年人网站在线观看 | 亚洲人成影视 |